IL136182A0 - 5,5'-arylidenebis(2-thiobarbituric) acids and salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydyal, antiviral and immuno-modulating activity - Google Patents

5,5'-arylidenebis(2-thiobarbituric) acids and salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydyal, antiviral and immuno-modulating activity

Info

Publication number
IL136182A0
IL136182A0 IL13618297A IL13618297A IL136182A0 IL 136182 A0 IL136182 A0 IL 136182A0 IL 13618297 A IL13618297 A IL 13618297A IL 13618297 A IL13618297 A IL 13618297A IL 136182 A0 IL136182 A0 IL 136182A0
Authority
IL
Israel
Prior art keywords
arylidenebis
thiobarbituric
acids
chlamydyal
arylidenebisbarbituric
Prior art date
Application number
IL13618297A
Other languages
English (en)
Original Assignee
Natural Drug Sciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natural Drug Sciences Llc filed Critical Natural Drug Sciences Llc
Publication of IL136182A0 publication Critical patent/IL136182A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids
    • C07D239/64—Salts of organic bases; Organic double compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/66—Thiobarbituric acids
    • C07D239/68—Salts of organic bases; Organic double compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
IL13618297A 1997-11-19 1997-11-19 5,5'-arylidenebis(2-thiobarbituric) acids and salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydyal, antiviral and immuno-modulating activity IL136182A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU1997/000372 WO1999025699A1 (fr) 1997-11-19 1997-11-19 Sels d'acides 5,5'-arylidenebisbarbituriques et 5,5'-arylidenebis(2-thiobarbituriques) et acides 5,5'-arylidenebis(2-thiobarbituriques) ayant une action antibacterienne, anti-chlamydiose, antivirale et immuno-modulatrice

Publications (1)

Publication Number Publication Date
IL136182A0 true IL136182A0 (en) 2001-05-20

Family

ID=20130166

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13618297A IL136182A0 (en) 1997-11-19 1997-11-19 5,5'-arylidenebis(2-thiobarbituric) acids and salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydyal, antiviral and immuno-modulating activity

Country Status (6)

Country Link
EP (1) EP1043318A4 (fr)
JP (1) JP2001523670A (fr)
AU (1) AU6125898A (fr)
CA (1) CA2310410A1 (fr)
IL (1) IL136182A0 (fr)
WO (1) WO1999025699A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG90259A1 (en) * 2000-08-17 2002-07-23 Control Ox Oy Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections
RU2400233C1 (ru) 2009-07-07 2010-09-27 Общество с ограниченной ответственностью "Вирфарм" Способ лечения заболеваний печени различного генеза

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB416273A (en) * 1933-03-31 1934-09-13 Heyden Chem Fab Manufacture of derivatives of oxy-and amino-pyridine compounds
GB674807A (en) * 1949-11-09 1952-07-02 Roche Products Ltd Compounds of phenyl ethyl barbituric acid with bases and the manufacture thereof
US3402175A (en) * 1960-04-16 1968-09-17 Knoll Ag Salt of phenethylbarbituric acid
SU1129202A1 (ru) * 1981-09-08 1984-12-15 Предприятие П/Я Г-4740 Способ получени 2-арилиденкарбонильных соединений
JPH0638174B2 (ja) * 1987-03-16 1994-05-18 三菱製紙株式会社 電子写真平版印刷版
DE3823255A1 (de) * 1988-07-08 1990-01-11 Siemens Ag Elektrische isolierung
WO1996025402A1 (fr) * 1995-02-13 1996-08-22 Gulliya Kirpal S Nouvelles utilisations d'analogues de l'acide barbiturique

Also Published As

Publication number Publication date
EP1043318A1 (fr) 2000-10-11
AU6125898A (en) 1999-06-07
CA2310410A1 (fr) 1999-05-27
JP2001523670A (ja) 2001-11-27
WO1999025699A1 (fr) 1999-05-27
EP1043318A4 (fr) 2001-02-07

Similar Documents

Publication Publication Date Title
PL329177A1 (en) Derivatives of azahexane ehxibiting antiviral activity
IL117752A (en) Stabilized aqueous interferon alpha solutions
EP1024130A4 (fr) Derives de biphenyl-5-acide alcanoique et leurs applications
EP0760014A4 (fr) Identification et utilisation de composes antiviraux
AU4125099A (en) Antiviral phosphorus derivatives of 4'-thio-5-ethyl-2'-deoxyuridine
HUP0004477A3 (en) Herbicidal 3(-1,2-benzisothiazol or isoxazol-5 yl)-substituted pyrimidine derivatives, intermediates, preparation and use thereof
PL336802A1 (en) Antiviral pharmaceutic composition comprising glycirisic acid and at least one protein of antiviral activity
GB9811762D0 (en) S'-Deoxy-cytidine derivatives
AU7623991A (en) Antiviral agents
PL332904A1 (en) Dihydropyrones of improved antiviral activity
AU7804798A (en) Base-modified derivatives of 2',5'-oligoadenylate and antiviral uses thereof
EP1019404A4 (fr) Acyclonucleosides de purine utilises comme agents antiviraux
PL327686A1 (en) Derivatives of @-amino 5,6-dichlorobenzimidazole exhibiting antiviral activity
EP1011701A4 (fr) Extraits d'especes de sauge dotees d'une activite antivirale
HU9700116D0 (en) Difluorostatone antiviral agents
IL136182A0 (en) 5,5'-arylidenebis(2-thiobarbituric) acids and salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydyal, antiviral and immuno-modulating activity
AU9261198A (en) Antiviral agent
AU8334691A (en) Antiviral agent
AU5678798A (en) Antiviral agents
AU1850092A (en) 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
AU7343398A (en) Diphenylacetic acid derivatives and their use as antiviral agents
IT1291394B1 (it) Composizioni ad attivita' condroprotettiva per il trattamento di artropatie traumatiche e/o cronico-degenerative.
GB8920027D0 (en) 2',3'-dideoxynucleosides and their use as antiviral agents
HUP9903260A3 (en) 2,4-diaminopyrimidine derivatives with antibiotic activity, preparation and use thereof
ITMI930794A0 (it) Furoilmetilamminoacidi ad attivita' antivirale e immonomodulante